Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Analgesics and pulp vitality test response in symptomatic irreversible pulpitis
IRCT20200322046836N1Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-blind trial of acetaminophen and Placebo-COD Research Private Ltd in irreversible pulpitis (3 arms), sponsored by Tehran University of Medical Sciences. Primary endpoints: Pulp response to cold test in teeth with symptomatic irreversible pulpitis and sound teeth and Pulp response to electric pulp tester in teeth with symptomatic irreversible pulpitis and sound teeth. Started May 2019; status: completed.
02
Drugs
acetaminophenPlacebo-COD Research Private Ltd
03
Conditions
irreversible pulpitis
Beyond the preview
Go deeper on IRCT20200322046836N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200322046836N1.